BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33542244)

  • 1. Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
    Klemke L; De Oliveira T; Witt D; Winkler N; Bohnenberger H; Bucala R; Conradi LC; Schulz-Heddergott R
    Cell Death Dis; 2021 Feb; 12(2):155. PubMed ID: 33542244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
    Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
    Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
    Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
    J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration inhibitory factor enhances inflammation via CD74 in cartilage end plates with Modic type 1 changes on MRI.
    Xiong C; Huang B; Cun Y; Aghdasi BG; Zhou Y
    Clin Orthop Relat Res; 2014 Jun; 472(6):1943-54. PubMed ID: 24569872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
    Sun H; Zhang X; Zhao L; Zhen X; Huang S; Wang S; He H; Liu Z; Xu N; Yang F; Qu Z; Ma Z; Zhang C; Zhang Y; Hu Q
    J Cell Mol Med; 2015 Apr; 19(4):836-49. PubMed ID: 25661015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
    Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T
    FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem/progenitor cells.
    Ohta S; Misawa A; Fukaya R; Inoue S; Kanemura Y; Okano H; Kawakami Y; Toda M
    J Cell Sci; 2012 Jul; 125(Pt 13):3210-20. PubMed ID: 22454509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.
    Bozzi F; Mogavero A; Varinelli L; Belfiore A; Manenti G; Caccia C; Volpi CC; Beznoussenko GV; Milione M; Leoni V; Gloghini A; Mironov AA; Leo E; Pilotti S; Pierotti MA; Bongarzone I; Gariboldi M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):16. PubMed ID: 28114961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion.
    Liehn EA; Kanzler I; Konschalla S; Kroh A; Simsekyilmaz S; Sönmez TT; Bucala R; Bernhagen J; Weber C
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2180-6. PubMed ID: 23868943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD74 Signaling Links Inflammation to Intestinal Epithelial Cell Regeneration and Promotes Mucosal Healing.
    Farr L; Ghosh S; Jiang N; Watanabe K; Parlak M; Bucala R; Moonah S
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):101-112. PubMed ID: 32004754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIF and D-DT are potential disease severity modifiers in male MS subjects.
    Benedek G; Meza-Romero R; Jordan K; Zhang Y; Nguyen H; Kent G; Li J; Siu E; Frazer J; Piecychna M; Du X; Sreih A; Leng L; Wiedrick J; Caillier SJ; Offner H; Oksenberg JR; Yadav V; Bourdette D; Bucala R; Vandenbark AA
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8421-E8429. PubMed ID: 28923927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
    Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
    Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms.
    Ochi A; Chen D; Schulte W; Leng L; Moeckel N; Piecychna M; Averdunk L; Stoppe C; Bucala R; Moeckel G
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F767-F780. PubMed ID: 28539339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD74 expression and its therapeutic potential in thyroid carcinoma.
    Cheng SP; Liu CL; Chen MJ; Chien MN; Leung CH; Lin CH; Hsu YC; Lee JJ
    Endocr Relat Cancer; 2015 Apr; 22(2):179-90. PubMed ID: 25600560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
    Koga K; Kenessey A; Ojamaa K
    Am J Physiol Heart Circ Physiol; 2013 Jan; 304(2):H282-93. PubMed ID: 23144312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
    Richard V; Kindt N; Decaestecker C; Gabius HJ; Laurent G; Noël JC; Saussez S
    Oncol Rep; 2014 Aug; 32(2):523-9. PubMed ID: 24939415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.
    Heinrichs D; Knauel M; Offermanns C; Berres ML; Nellen A; Leng L; Schmitz P; Bucala R; Trautwein C; Weber C; Bernhagen J; Wasmuth HE
    Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17444-9. PubMed ID: 21969590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor confers resistance to senescence through CD74-dependent AMPK-FOXO3a signaling in mesenchymal stem cells.
    Xia W; Zhang F; Xie C; Jiang M; Hou M
    Stem Cell Res Ther; 2015 Apr; 6(1):82. PubMed ID: 25896286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
    Zheng YX; Yang M; Rong TT; Yuan XL; Ma YH; Wang ZH; Shen LS; Cui L
    World J Gastroenterol; 2012 May; 18(18):2253-61. PubMed ID: 22611320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
    Wu LH; Xia HH; Ma WQ; Zhong HJ; Xu HX; Wang YM; Yang RJ; Wang LJ; Chen Y; Li L; He XX
    Front Biosci (Landmark Ed); 2017 Mar; 22(8):1365-1378. PubMed ID: 28199208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.